LifeMD to offer Novo's Ozempic at $499 per month to eligible US cash-paying customers-March 2024-www.financetom.com

LifeMD to offer Novo's Ozempic at $499 per month to eligible US cash-paying customers

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

LifeMD to offer Novo's Ozempic at $499 per month to eligible US cash-paying customers

Sep 30, 2025 5:39 AM

Sept 30 (Reuters) - Telehealth firm LifeMD ( LFMD ) said

on Tuesday it would collaborate with Novo Nordisk to

offer its diabetes drug Ozempic at $499 per month to eligible

U.S. patients, including those who are insured and whose plans

do not cover it.

Previous page： --Fifth Third Bancorp Keeps Quarterly Dividend at $0.37 a Share, Payable April 15 to Holders of Record on March 31 Next page： US FTC firings could put consumer rulings in legal limbo

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

--Fifth Third Bancorp Keeps Quarterly Dividend at $0.37 a Share, Payable April 15 to Holders of Record on March 31

Mar 20, 2025

01:16 PM EDT, 03/20/2025 (MT Newswires) -- Price: 39.52, Change: +0.05, Percent Change: +0.14 ...

US FTC firings could put consumer rulings in legal limbo

Mar 20, 2025

* Firing 2 Democratic commissioners could lead to court challenges * FTC would have soon had Republican majority even without firings * Spokesperson says FTC will pursue cases against Big Tech By Jody Godoy NEW YORK, March 20 (Reuters) - President Donald Trump's firing of two commissioners at the Federal Trade Commission puts the U.S. consumer protection in uncharted waters,...

Blake Lively seeks dismissal of Justin Baldoni's $400 million defamation lawsuit

Mar 20, 2025

NEW YORK, March 20 (Reuters) - Actress Blake Lively on Thursday asked a U.S. judge to dismiss actor Justin Baldoni's $400 million defamation lawsuit, calling it a vengeful and rambling case that does not belong in federal court. In a filing in Manhattan federal court, Lively said the law prohibits weaponizing defamation lawsuits such as Baldoni's to retaliate against people...

Academy Sports Q4: EPS Beat, 3% Comps Dip, Sees Tough Q1, Bets On Turnaround Later In 2025 And More

Mar 20, 2025

On Thursday, Academy Sports and Outdoors, Inc. ( ASO ) reported fourth-quarter adjusted earnings per share of $1.96, beating the street view of $1.83. Quarterly sales of $1.676 billion (down 6.6% year over year) missed the analyst consensus estimate of $1.677 billion by a hairline. Comparable sales declined 3% in the quarter under review, compared with a 3.6% dip in the...